Literature DB >> 24419118

Are dose-dense and triplet chemotherapy regimens optimal adjuvant therapy in the majority of women with node-positive early breast cancer?

Eugene J Moylan1, Louise C Connell, Seamus O'Reilly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24419118     DOI: 10.1200/JCO.2013.53.6771

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Reply to E.J. Moylan et al.

Authors:  Sandra M Swain; Gong Tang; Charles E Geyer
Journal:  J Clin Oncol       Date:  2014-01-13       Impact factor: 44.544

Review 2.  Recent Advances in the Neoadjuvant Treatment of Breast Cancer.

Authors:  Gábor Rubovszky; Zsolt Horváth
Journal:  J Breast Cancer       Date:  2017-06-26       Impact factor: 3.588

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.